Safety and efficacy of ASTX727 in patients with CMML from Phase II and Phase III ASCERTAIN studies
Michael Savona • 5 May 2023
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter